Princeton, NJ. January 2024: Andy Bala, CEO of Delphine Diagnostics, attended the Princeton Tech Meetup focused on Artificial Intelligence in Healthcare.
Some of the key takeaways are:
- Artificial intelligence-based solutions have recently gained traction in pharma drug discovery, clinical trials, hospital health networks, and product manufacturing. Faster adoption led to better outcomes in business process efficiencies, improved patient outcomes (risk predictions, guidance for surgery planning, improved patient outcomes (such as social determinants, and value-based care for seniors), and of course, financials – Better Operating margin improvements ensuring that the health of the Hospital Health Networks stay robust.
- Responding to a volley of questions from participants, the panelists shared insights on how to solve complex challenges such as bias in data leading to bias in Artificial Intelligence models, and how to improve the accuracy of AI models which could be due to lack of a relevant and real dataset to train models.
- The panel recommended using a governance committee framework with Scientists, Clinicians, Ethics, Compliance, D&I, and the board. The panel also recommended developing and using a responsible Artificial Intelligence model development framework.
We would like to thank Venu Moola and Chris Boroski for the great work done in selecting this much-needed topic and managing the Princeton Tech Meetup.This very engaging panel with such relevant insights would not have been possible without a great panel comprising of Donna Conroy – CEO SciMar ONE, Kash Patel – EVP & CDIO Hackensack Meridian Health, and Rohit Vashisht – CEO WhizAI. Lastly, many thanks Jim Barrood, CEO of Innovation+, who enabled effective interaction among the participants and panelists.
Delphine is proud to be a part of this rapidly growing area of Health Tech!